Reduced dose and intermittent treatment with lapatinib and trastuzumab for potent blockade of the HER pathway in HER2/neu-overexpressing breast tumor xenografts / Rimawi, Mf; Wiechmann, Ls; Wang, Yc; Huang, C; Migliaccio, I; Wu, Mf; Gutierrez, C; Hilsenbeck, Sg; Arpino, Grazia; Massarweh, S; Ward, R; Soliz, R; Osborne, Ck; Schiff, R.. - In: CLINICAL CANCER RESEARCH. - ISSN 1078-0432. - STAMPA. - 17:(2011), pp. 1351-1361. [10.1158/1078-0432.CCR-10-1905]
Reduced dose and intermittent treatment with lapatinib and trastuzumab for potent blockade of the HER pathway in HER2/neu-overexpressing breast tumor xenografts.
ARPINO, GRAZIA;
2011
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Rimawi_Clin Cancer Res-2011.pdf
accesso aperto
Tipologia:
Documento in Post-print
Licenza:
Accesso privato/ristretto
Dimensione
849.68 kB
Formato
Adobe PDF
|
849.68 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
